What Will JAK Inhibitor Safety Jitters Mean For Drug Sales?
FDA Delays Decisions On Pfizer, Lilly/Incyte Drugs
Together with a similar delay for AbbVie’s Rinvoq, the delays appear to stem from a study that raised concerns about the class. But the potential sales impact is less clear.
